
Excelerate Health Ventures
Description
Excelerate Health Ventures is a dedicated venture capital firm based in Durham, North Carolina, specializing in seed and early-stage investments within the digital healthcare sector. The firm's core focus encompasses healthcare software, tech-enabled healthcare services, and medical device companies, aiming to support innovative solutions that address critical needs in the evolving healthcare landscape. Their investment thesis centers on identifying and nurturing startups poised to disrupt traditional healthcare models through technology and scalable services.
Since its inception, Excelerate Health Ventures has demonstrated a consistent commitment to its niche. The firm successfully raised its first fund, Excelerate Health Ventures Fund I, which closed at $10 million. Building on this foundation, they launched and closed their second fund, Excelerate Health Ventures Fund II, securing $20 million in commitments in 2020. This capital allows them to provide significant support to their portfolio companies. For their second fund, the firm typically targets initial investments ranging from $500,000 to $1.5 million, planning to back approximately 10 to 12 companies with this capital.
Excelerate Health Ventures has built a robust portfolio, having made over 30 investments in promising digital health companies to date. Their strategic guidance and capital have contributed to the growth of several startups, leading to 5 successful exits, demonstrating their ability to identify and scale valuable healthcare innovations. The firm's deep industry expertise and network are leveraged to provide operational support and strategic advice, helping founders navigate the complex healthcare market and achieve their growth objectives.
Investor Profile
Excelerate Health Ventures has backed more than 28 startups, with 2 new investments in the last 12 months alone. The firm has led 13 rounds, about 46% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical, Analytics.
- Typical check size: $500K – $1.5M.
Stage Focus
- Series Unknown (36%)
- Series A (29%)
- Seed (18%)
- Series B (11%)
- Debt Financing (4%)
- Series C (4%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Analytics
- Hospital
- Information Technology
- Saas
- Software
- Risk Management
- Clinical Trials
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.